Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem in infants with late-onset sepsis
NCT01551394Phase 3Completed
- Sponsor
- Penta Foundation
- Start
- Sep 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meropenem in late-onset neonatal sepsis (LONS), sponsored by Penta Foundation. Started Sep 2012; status: completed.
02
Drugs
meropenem
03
Conditions
late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NCT01551394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01551394.